<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR16">
 <label>16.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lambert</surname>
    <given-names>JM</given-names>
   </name>
   <name>
    <surname>Chari</surname>
    <given-names>RV</given-names>
   </name>
  </person-group>
  <article-title>Ado-trastuzumab Emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancer</article-title>
  <source>J Med Chem</source>
  <year>2014</year>
  <volume>57</volume>
  <fpage>6949</fpage>
  <lpage>6964</lpage>
  <pub-id pub-id-type="doi">10.1021/jm500766w</pub-id>
  <?supplied-pmid 24967516?>
  <pub-id pub-id-type="pmid">24967516</pub-id>
 </element-citation>
</ref>
